relugolix   Click here for help

GtoPdb Ligand ID: 5586

Synonyms: Orgovyx® | Ryeqo® (relugolix-estradiol-norethisterone acetate) | TAK 385 | TAK-385
Approved drug
relugolix is an approved drug (FDA (2020), EMA (2021))
Compound class: Synthetic organic
Comment: Relugolix (TAK-385) is a non-peptide, orally active GnRH receptor antagonist [1]. Administration suppresses the hypothalamic-pituitary-gonadal axis. In males this causes chemical castration.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 2
Rotatable bonds 11
Topological polar surface area 160.33
Molecular weight 623.18
XLogP 4.28
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CONC(=O)Nc1ccc(cc1)c1sc2c(c1CN(C)C)c(=O)n(c(=O)n2Cc1c(F)cccc1F)c1ccc(nn1)OC
Isomeric SMILES CONC(=O)Nc1ccc(cc1)c1sc2c(c1CN(C)C)c(=O)n(c(=O)n2Cc1c(F)cccc1F)c1ccc(nn1)OC
InChI InChI=1S/C29H27F2N7O5S/c1-36(2)14-19-24-26(39)38(22-12-13-23(42-3)34-33-22)29(41)37(15-18-20(30)6-5-7-21(18)31)27(24)44-25(19)16-8-10-17(11-9-16)32-28(40)35-43-4/h5-13H,14-15H2,1-4H3,(H2,32,35,40)
InChI Key AOMXMOCNKJTRQP-UHFFFAOYSA-N
Selectivity at GPCRs
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
GnRH1 receptor Hs Antagonist Antagonist 9.5 pIC50 - 1
pIC50 9.5 (IC50 3.3x10-10 M) [1]
GnRH1 receptor Rn Antagonist Antagonist 9.5 pIC50 - 1
pIC50 9.5 (IC50 3.3x10-10 M) [1]